202
Views
131
CrossRef citations to date
0
Altmetric
Original Articles

Neurologic Effects of Manganese in Humans: A Review

Pages 153-163 | Published online: 19 Jul 2013

References

  • Baxter PJ, Adams PH, Aw T-C, et al. Hunter's Diseases of Occu-pations. 9th ed. London, U.K.: Arnold, 2000: 107.
  • Schuler P. Oyanguren H, Maturana V, et al. Manganese poison-ing: environmental and medical study at a Chilean mine. Ind Med Surg. 1957; 26: 167–73.
  • Hayes AW. Principles and Methods of Toxicology. 4th ed. Philadelphia, PA: Taylor and Francis, 2001: 659–60.
  • Tanaka S, Lieben J. Manganese poisoning and exposure in Pennsylvania. Arch Environ Health. 1969: 19:674–84.
  • Davis JM. Manganese and Rhenium. In: Bingham E, Cohrssen B, Powell CH ( eds). Patty's Toxicology. 5th ed. Vol 3. New York: John Wiley & Sons, 2001.
  • Roels H, Lauwerys R, Buchet J-P, et al. Epidemiological survey among workers exposed to manganese: effects on lung, central nervous system, and some biological indices. Am J Ind Med. 1987; 11: 307–27.
  • Boojar MMA, Goodarzi E A longitudinal follow-up of pul-monary function and respiratory symptoms in workers exposed to manganese. J Occup Environ Med. 2002; 44: 282–90.
  • Penalver R. Manganese poisoning: The 1954 Ramazzini oration. Ind Med Surg. 1955; 24: 1–7.
  • von Oettingen WF. Manganese: Its distribution, pharmacology and health hazards. Physiol Rev. 1935; 15: 175–201.
  • Mena I, Horiuchi K, Burke K, et al. Chronic manganese poi-soning. Individual susceptibility and absorption of iron. Neurol-ogy. 1969; 19: 1000–6.
  • Pal PK, Samii A, Caine DB. Manganese neurotoxicity: a review of clinical features, imaging and pathology. Neurotoxicology. 1999; 20: 227–38.
  • Wennberg A, Hagman M, Johansson L. Preclinical neurophysi-ological signs of parkinsonism in occupational manganese exposure. Neurotoxicology. 1992; 13: 2714.
  • Mergler D, Baldwin M. Early manifestations of manganese neu-rotoxicity in humans: an update. Environ Res. 1997; 73: 92–100.
  • Frumkin H, Solomon G. Manganese in the U.S. gasoline supply. Am J Ind Med. 1997; 31: 107–15.
  • Solomon GM, Huddle AM, Silbergeld E, et al. Manganese in gasoline: are we repeating history? New Solutions. 1997;17-25.
  • Landrigan PJ. MMT, dejà vu and national security [editorial]. Am J Ind Med. 2001; 39: 434–5.
  • Zayed J. Use of MMT in Canadian gasoline: health and envi-ronment issues. Am J Ind Med. 2001; 39: 426–33.
  • Lyznicki JM, Karlan MS, Khan MK. Manganese in gasoline. J Occup Environ Med. 1999; 41: 140–3.
  • Documentation of the TLV's and BEI's. 7th ed. Cincinnati, OH: American Conference of Governmental Industrial Hygienists, 2001.
  • Apostoli P, Lucchini R, Alessio L. Are current biomarkers suit-able for the assessment of manganese exposure in individual workers? Am J Ind Med. 2000; 37: 283–90.
  • Couper J. On the effects of black oxide of manganese when inhaled into the lungs. Br Ann Med Pharmacol. 1837; 1: 41–2.
  • Mergler D, Huel G, Bowler R, et al. Nervous system dysfunction among workers with long-term exposure to manganese. Environ Res. 1994; 64: 151–80.
  • Donaldson J, LaBella FS, Gesser D. Enhanced autoxidation of dopamine as a possible basis of manganese neurotoxicity. Neu-rotoxicology. 1980; 2: 53–64.
  • Lucchini R, Albini E, Placidi D, et al. Brain magnetic resonance imaging and manganese exposure. Neurotoxicology. 2000; 21: 769–76.
  • Dietz MC, Ihrig A, Wrazidlo W, et al. Results of magnetic reso-nance imaging in long-term manganese dioxide-exposed work-ers. Environ Res. 2001; 85: 37–40.
  • Zheng YX, Chan P, Pan ZF, et al. Polymorphism of metabolic genes and susceptibility to occupational chronic manganism. Biomarkers. 2002; 7: 337–46.
  • Rodier J. Manganese poisoning in Moroccan miners. Br J Ind Med. 1955; 12: 21–35.
  • Barbeau A, Inoue N, Cloutier T. Role of manganese in dystonia. In Eldridge R, Fahn S (eds). Advances in Neurology. New York: Raven Press, 1976: 339-52.
  • Huang C-C, Chu N-S, Lu C-S, et al. Chronic manganese intoxi-cation. Arch Neurol. 1989; 46: 1104–6.
  • Mena I, Mann 0, Fuenzalida 5, et al. Chronic manganese poi-soning. Clinical picture and manganese turnover. Neurology. 1967; 17: 128–36.
  • Greenhouse AH. Heavy metals and the nervous system. Clin Neuropharmacol. 1982; 5: 45–92.
  • Huang G-C, Chu N-S, Lu G-S, et al. Long-term progression in chronic manganism: ten years of follow-up. Neurology. 1998; 50: 698–700.
  • Shinotoh H, Snow BJ, Chu N-S, et al. Presynaptic and postsy-naptic striatal dopaminergic function in patients with man-ganese intoxication: a positron emission tomography study. Neurology. 1997; 48: 1053–6.
  • Lu C-S, Huang C-C, Chu N-S, et al. Levodopa failure in chronic manganism. Neurology. 1994; 44: 1600–2.
  • Huang C-C, Lu C-S, Chu N-S, et al. Progression after chronic manganese exposure. Neurology. 1993; 43: 1479–83.
  • Young R. Update on Parkinson's disease. Am Fain Physician. 1999; 59: 2155-67, 2169–70.
  • Edsall DL, Wilbur FP, Drinker CK. The occurrence, course and prevention of chronic manganese poisoning. J Ind Hyg. 1919; 1: 183–93.
  • Pentschew A, Kovatch RM. Experimental manganese encepha-lopathy in workers. J Neuropathol Exp Neurol. 1963; 22: 488–99.
  • Neff NH, Barrett RE, Costa E. Selective depletion of caudate nucleus dopamine and serotonin during chronic manganese dioxide administration to squirrel monkeys. Experientia. 1969; 25: 1140–1.
  • Dastur DK, Manghani DK, Raghavendran KV. Distribution and fate of 54Mn in the monkey: studies of different parts of the cen-tral nervous system and other organs. J Clin Invest. 1971; 50: 9–20.
  • Shukla GS, Chandra SV, Seth PR. Effect of manganese on the levels of DNA, RNA, DNase and RNase in cerebrum, cerebellum and rest of brain regions of rat. Acta Pharmacol Toxicol. 1976; 39: 562–9.
  • Chandra SV, Shukla GS. Manganese encephalopathy in growing rats. Environ Res. 1978; 15: 28–37.
  • Bird ED, Anton AH, Bullock B. The effect of manganese inhala-tion on basal ganglia dopamine concentrations in rhesus monkey. Neurotoxicology 1984; 5: 59–66.
  • Morganti JB, Lown BA, Stineman CH, et al. Uptake, distribution and behavioral effects of inhalation exposure to managanese (Mn02) in the adult mouse. Neurotoxicology. 1985; 6: 1–16.
  • Brouillet EP, Shinobu L, McGarvey U, et al. Manganese injec-tion into the rat striatum produces excitotoxic lesions by impair-ing energy metabolism. Exp Neurol. 1993; 120: 89–94.
  • Olanow CW, Good PF, Shinotoh H, et al. Manganese intoxica-tion in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study. Neurology. 1996; 46: 492–8.
  • Witholt R, Gwiazda RH, Smith DR. The neurobehavioral effects of subchronic manganese exposure in the presence and absence of pre-parkinsonism. Neurotoxicol Teratol. 2000; 22: 851–61.
  • Shukakidze A, Khetsuriani R, Darbaidze M, et al. The behavioral disorders in rats exposed to acute and chronic manganese intoxication. Ann Biomed Res Educ. 2001; 1: 4–13.
  • Abd El Naby S, Hassanein M. Neuropsychiatric manifestations of chronic manganese poisoning. J Neurol Neurosurg Psychia-try. 1965; 28: 282–8.
  • Greenhouse AH. Manganese intoxication in the United States. Transactions of the American Neurological Association, 1971; 96: 248–9.
  • Chandra SV, Seth PR, Mankeshwar JK. Manganese poisoning: clinical and biochemical observations. Environ Res. 1974; 7: 374–80.
  • Sark M, Markicevic A, Hrustic 0. Occupational exposure to manganese. Br J Ind Med. 1977; 34: 114–8.
  • Chandra SV, Shukla GS, Srivastava RS. An exploratory study of manganese exposure to welders. Clin Toxicol. 1981; 18: 407–16.
  • Barbeau A, Roy M, Bernier G, et al. Ecogenetics of Parkinson'sdisease: prevalence and environmental aspects in rural areas. Can J Neurol Sci. 1987; 14: 36–41.
  • Ferraz HB, Bertolucci PHF, Pereira JS, et al. Chronic exposureto the fungicide maneb may produce symptoms and signs of CNS manganese intoxication. Neurology. 1988; 38: 550–3.
  • Kondakis XG, Makris N, Leotsinidis M, et al. Possible health effects of high manganese concentration in drinking water. Arch Environ Health, 1989; 44: 175–78.
  • Wang J-D, Huang C-C, Hwang Y-H, et al. Manganese induced parkinsonism: an outbreak due to an unrepaired ventilation control system in a ferromanganese smelter. Br J Ind Med. 1989; 46: 856–9.
  • Hertzman C, Wiens M, Bowering D, et al. Parkinson's disease: a case-control study of occupational and environmental risk fac-tors. Am J Ind Med. 1990; 17: 349–55.
  • Sjfigren B, Gustavsson P, Hogstedt C. Neuropsychiatric symp-toms among welders exposed to neurotoxic metals. Br J Ind Med. 1990; 47: 704–7.
  • Hogsted C, Andersson K, Hane M. A questionnaire approach to the monitoring of early disturbances in central nervous system functions. In: Aitio A. Ruhimake V, Vainio H ( eds). Biological Monitoring and Surveillance of Workers Exposed to Chemicals. Washington, DC: Hemisphere Publishing Corporation, 1984: 275-87.
  • Hua M-S, Huang C-C. Chronic occupational exposure to man-ganese and neurobehavioral function. J Clin Exp Neuropsychol. 1991; 13: 495–507.
  • Wennberg A, Iregren A, Struwe G, et al. Manganese exposure insteel smelters a health hazard to the nervous system. Scand J Work Environ Health. 1991; 17: 255–62.
  • Rods HA, Ghyselen P, Buchet JP, et al. Assessment of the per-missible exposure level to manganese in workers exposed to manganese dioxide dust. Br J Ind Med. 1992; 49: 25–34.
  • Lucchini R, Selis L, Folli D, et al. Neurobehavioral effects of manganese in workers from a ferroally plant after temporary cessation of exposure. Scand J Work Environ Health. 1995; 21: 143–9.
  • Ono J, Harada K, Kodaka R, et al. Manganese deposition in thebrain during long-term total parenteral nutrition. J Parenteral Enteral Nutr. 1995; 19: 310–12.
  • Dickerson RN. Manganese intoxication and parenteral nutri-tion. Nutrition. 2001; 17: 689–93.
  • Hochberg F, Miller G, Valenzuela R, et al. Late motor deficits ofChilean manganese miners: a blinded control study. Neurology. 1996; 47: 788–95.
  • Sjögren B, Iregren A, Frech W, et al. Effects on the nervous system among welders exposed to aluminium and manganese. Occup Environ Med. 1996; 53: 3240.
  • Goren JM, Johnson CC, Rybicki BA, et al. Occupational expo-sures to metals as risk factors for Parkinson's disease. Neurology. 1997; 48: 650–8.
  • Goren JM, Johnson CC, Rybicki BA, et al. Occupational expo-sure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. Neurotoxicology. 1999; 20: 239–48.
  • Hudnell HK. Effects from environmental Mn exposures: a review of the evidence from non-occupational exposure studies. Neurotoxicology. 1999; 20: 379–98.
  • a. Kim Y, Kim KS, Yang JS, et al. Increase in signal intensities on Ti-weighted magnetic resonance images in asymptomatic man-ganese-exposed workers. Neurotoxicology. 1999; 20: 901–8.
  • Lucchini R, Apostoli P, Perrone C, et al. Long term exposure to “low levels” of manganese oxides and neurofunctional changes in ferroalloy workers. Neurotoxicology. 1999; 20: 287–98.
  • Luse I, Bake MA, Bergmanis G, et al. Risk assessment of man-ganese. Central European J Public Health. 2000; 8 suppl: 51.
  • Deschamps FJ, Guillaumot M, Raux S. Neurological effects in workers exposed to manganese. J Occup Environ Med. 2001; 43: 127–32.
  • Racette BA, McGee-Minnich L, Moerlein SM, et al. Welding-related parkinsonism: clinical features, treatment, and patho-physiology. Neurology. 2001; 56: 8–13.
  • Rajput AH. Environmental toxins accelerate Parkinson's disease onset [editorial]. Neurology. 2001; 56: 4–5.
  • Pezzoli G, Canesi M, Antonini A, et al. Hydrocarbon exposure and Parkinson's disease [letter to the editor]. Neurology. 2000; 55: 667–73.
  • Sadak AR, Schulz PE. Welding-related parkinsonism: clinical features, treatment, and pathophysiology [letter to the editor]. Neurology. 2001; 57: 1738–9.
  • Racette BA, Perlmutter JS. Welding-related parkinsonisrn; clini-cal features, treatment, and pathophysiology [letter to the editor] . Neurology. 2001; 57: 1739.
  • Santos-Burgoa C, Rios C, Mercado LA, et al. Exposure to man-ganese: health effects on the general population, a pilot study in Central Mexico. Environ Res. 2001; 85: 90–104.
  • Sinczuk-Walczak H, Jakubowski M, Matczak W. Neurological and neurophysiological examinations of workers occupationally exposed to manganese. Int J Occup Meti Environ Health. 2001; 14: 329–37.
  • Sassine M-P, Mergler D, Bowler R, et al. Manganese accentuates adverse mental health effects associated with alcohol use disor-ders. Biological Psychiatry. 2002; 51: 909–21.
  • Cotzias GC. Manganese in health and disease. Physiol Rev. 1958; 38: 503–32.
  • Utter MF. The biochemistry of manganese. Med Clin North Am. 1976; 60: 713–27.
  • Barbeau A. Manganese and extrapyramidal disorders. Neuro-toxicology. 1984; 5: 13–36.
  • Donaldson J, Barbeau A. Manganese neurotoxicity: possible clues to the etiology of human brain disorders. In: Gabay S, Harris J, Ho BT ( eds). Metal Ions in Neurology and Psychiatry. New York: Alan R. Liss, 1985; 259-85.
  • Donaldson J. The physiopathologic significance of manganese in brain: its relation to schizophrenia and neurodegenerative disorders. Neurotoxicology. 1987; 8: 451–62.
  • Bleecker ML. Parkinsonisrn: a clinical marker of exposure to neurotoxins. Neurotoxicol Teratol, 1988; 10: 475–8.
  • Caine DI 3, Chu N-S, Huang C-C, et al. Manganism and idio-pathic parkinsonisrn: similarities and differences. Neurology. 1994; 44: 1583-6.
  • Barceloux DG. Manganese. Clin ToxicoL 1999; 37: 293–307.
  • Mergler D. Neurotoxk effects of low level exposure to man-ganese in human populations. Environ Res. 1999;80;99–102.
  • Agency for Toxic Substances and Disease Registry. Toxicological Profile for Manganese. Atlanta, GA: ATSDR, 2000.
  • Albin RI. Basal ganglia neurotoxins. Clin Neurobehav Toxicol, 2000; 18: 665–80
  • Lee J-W, Manganese intoxication. Arch NeuroL 2000; 57: 597–9.
  • Aschner M. Manganese: brain transport and emerging research needs. Environ Health Perspect. 2000; 108 (suppl 3): 429-32.
  • Mergler D. Manganese: the controversial metal. At what levels can deleterious effects occur? Can J Neurol Sci. 1996; 23: 93–4.
  • Hermanus MA. Manganese-a public health concern: Its rele-vance for occupational health and safety policy and regulation in South Africa. Int J Occup Environ Health, 2000;6;151–69.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.